Sol-gel technologies reports third quarter 2023 financial results and provides corporate update

Ness ziona, israel, nov. 09, 2023 (globe newswire) -- sol-gel technologies, ltd. (nasdaq: slgl) (“sol-gel”), a dermatology company leveraging innovative approaches to develop pioneering treatments for patients with severe skin conditions, and with two approved large-category dermatology products, twyneo® and epsolay®, today announced financial results for the third quarter ended september 30, 2023 and provided a corporate update.
SLGL Ratings Summary
SLGL Quant Ranking